Cryoport, Inc.
Industrials sector | Integrated Freight & Logistics industry
Metrics for CYRX
| Price | $10.21 |
|---|---|
| Shares Outstanding | 50.2M |
| All-Time Low | $1.03 |
| 52-Week Low | $4.58 |
Balance Statement Metrics
| Net Cash / Share | $2.97 |
|---|---|
| Net Current Assets / Share | $4.26 |
| Net Tangible Assets / Share | $6.82 |
| Shares Outstanding Ave Change (Annual) | 0.2% |
| Shares Δ YoY | 1.91% |
| Avg CA Burn (Annual %) | -20.16% (as of 3-23-2026) |
| Avg CA Burn (Quarterly %) | 9.17% (as of 3-23-2026) |
Earning Metrics
| Max Earning Power / Share | $-0.08 |
|---|---|
| Adjusted Earning Power |
$-2.21
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.22%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 3-23-2026) |
| Avg EBITDA (5Q) | 82K (as of 3-23-2026) |
| Avg Net Income (5Y) | -131.8M (as of 3-23-2026) |
| Avg Net Income (5Q) | 11.2M (as of 3-23-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-23-2026 |
| Consecutive Years Paid | No | 3-23-2026 |
| Pays Dividend | No | 3-23-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 3-23-2026 |
| Net Income Positive | No | 3-23-2026 |
| Current Dividend Streak | No | 3-23-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $6.02 | 299.9M ($299,881,000) | 49.9M (49,850,793) |
| 2025-09-30 | Quarterly | $6.18 | 309.3M ($309,333,000) | 50.1M (50,068,904) |
| 2025-06-30 | Quarterly | $6.26 | 314.8M ($314,813,000) | 50.3M (50,278,559) |
| 2025-03-31 | Quarterly | $3.91 | 196.2M ($196,162,000) | 50.1M (50,137,218) |
| 2024-12-31 | Quarterly | $2.92 | 145.5M ($145,499,000) | 49.9M (49,908,254) |
| 2024-12-31 | Annual | $2.92 | 145.5M ($145,499,000) | 49.9M (49,908,254) |
| 2024-09-30 | Quarterly | $3.16 | 156.4M ($156,425,000) | 49.4M (49,430,583) |
| 2023-12-31 | Annual | $3.27 | 160M ($159,963,000) | 49M (48,971,026) |
| 2022-12-31 | Annual | $4.04 | 195.4M ($195,437,000) | 48.3M (48,334,280) |
| 2021-12-31 | Annual | $5.71 | 283.2M ($283,172,000) | 49.6M (49,616,154) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 228.4M ($228,385,000) |
| 2023-12-31 | 233.3M ($233,255,000) |
| 2022-12-31 | 237.3M ($237,277,000) |
| 2021-12-31 | 222.6M ($222,608,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-04-24 | 50,197,906 | +341,771 |
| 2026-03-17 | 49,856,135 | -212,769 |
| 2025-11-10 | 50,068,904 | +1,936 |
| 2025-09-22 | 50,066,968 | -32 |
Short Interest Changes
Latest short-interest change: 2,256,431 shares (5.42% of float) | Days to cover: 5.01
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-04-27 | 2,256,431 shares | +85,796 | +3.95% |
| 2026-04-17 | 2,170,635 shares | -92,672 | -4.09% |
| 2026-03-25 | 2,263,307 shares | -105,341 | -4.45% |
| 2026-03-12 | 2,368,648 shares | -208,078 | -8.08% |
| 2026-02-27 | 2,576,726 shares | -221,951 | -7.93% |
| 2026-02-11 | 2,798,677 shares | -164,337 | -5.55% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.